Accelerate Long Island
13
223K
9
1.08
1
0.31
- Stages of investment
- Areas of investment
Summary
Accelerate Long Island is the famous Corporate Investor, which was founded in 2011. The main department of described Corporate Investor is located in the Melville. The venture was found in North America in United States.
The typical case for the fund is to invest in rounds with 2 participants. The meaningful sponsors for the fund in investment in the same round are the Long Island Emerging technologies Fund (LIETF), Topspin Partners, New York Angels. In the next rounds fund is usually obtained by The Thiel Foundation, National Institutes of Health, Grand Central Tech.
Besides, a startup requires to be at the age of 1 and less years to receive the investment from the fund. Among the most popular fund investment industries, there are Commercial, Artificial Intelligence. Among the various public portfolio startups of the fund, we may underline Envisagenics For fund there is a match between the location of its establishment and the land of its numerous investments - United States.
The fund is constantly included in less than 2 deals per year. Deals in the range of 100 thousands - 1 million dollars are the general things for fund. The top activity for fund was in 2014.
Investments analytics
Analytics
- Total investments
- 13
- Lead investments
- 1
- Rounds per year
- 1.08
- Follow on index
- 0.31
- Investments by industry
- Biotechnology (12)
- Therapeutics (4)
- Health Care (3)
- Medical Device (3)
- Health Diagnostics (3) Show 10 more
- Investments by region
-
- United States (13)
- Peak activity year
- 2015
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 9
- Avg. valuation at time of investment
- 1M
- Group Appearance index
- 0.69
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| DepYmed | 22 Dec 2015 | Biotechnology | Seed | 100K | United States, New York |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.